<DOC>
	<DOCNO>NCT00044759</DOCNO>
	<brief_summary>To compare safety efficacy piperacillin/tazobactam ( 4 g/500 mg ) administer intravenously every 6 hour cefepime ( 2 g ) administer intravenously every 8 hour empiric treatment neutropenic fever patient hematologic malignancy lymphoma .</brief_summary>
	<brief_title>Study Comparing Safety Efficacy Piperacillin/Tazobactam Cefepime Patients With Hematologic Malignancy Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Hematologic Neoplasms</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<mesh_term>Cefepime</mesh_term>
	<criteria>Hospitalized male female patient , 18 year age old Patients leukemia ( acute lymphocytic leukemia [ ALL ] , acute myelogenous leukemia [ AML ] , chronic lymphocytic leukemia [ CLL ] , chronic myelogenous leukemia [ CML ] ) , newly diagnose , initial induction , reinduction , intensification chemotherapy bone marrow ( allogenic , syngeneic , autologous ) peripheral blood stemcell transplant OR Patients lymphoma , Hodgkin 's disease , multiple myeloma , myelodysplastic syndrome myelodysplasia ( refractory anemia [ RA ] , refractory anemia ring sideroblast [ RARS ] , refractory anemia excess blast [ RAEB ] , refractory anemia excess blast transformation leukemia [ RAEBT ] , chronic myelomonocytic leukemia [ CMML ] . Fever , define oral temperature ≥ 37.9°C /100.2°F , rectal temperature ≥ 38.4°C /101.4°F , tympanic temperature ≥ 38°C /100.4°F The presence clinically acute chronic disease condition , opinion investigator , may interfere patient 's ability safely comply condition protocol , could preclude evaluation patient 's response could make completion therapy unlikely Neutropenia associate syndromes associate high risk bacterial infection ( eg . chronic benign neutropenia Kostmann 's syndrome ) Neutropenia due primary bone marrow failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Hematologic</keyword>
	<keyword>Neoplasms</keyword>
</DOC>